Jonušaitė, I., N. Giedraitienė, G. Kaubrys, and R. Kizlaitienė. “The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab”. Neurologijos seminarai 27, no. Nr. 3 (97) (March 20, 2024): 127–135. Accessed July 17, 2024. https://www.journals.vu.lt/neurologijos_seminarai/article/view/34911.